← Back to all trials
Recruiting
NCT07376889
Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia
Conditions: Staphylococcus Aureus Bacteremia
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 2096
Sponsor: Intermountain Health Care, Inc.
Location: Platte Valley Hospital Brighton Colorado
Summary
The purpose of this study is to see if, in selected patients with a serious bacterial infection of the bloodstream, treating the bacterial infection with a combination of antibiotics is more effective than treating the infection with a single antibiotic. Participants must have blood cultures which are positive for a certain type of bacteria.
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Alive and admitted to an Intermountain Health (IH) hospital acute care unit at enrollment
* Initial positive blood culture with either methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-susceptible Staphylococcus aureus (MSSA), collected:
1. on or during the index admission to an IH hospital, or
2. in an ambulatory setting (laboratory, clinic or emergency department) within 48 hours of the index admission, or
3. at a non-IH network hospital within 24 hours of subsequent transfer to an IH hospital
Exclusion Criteria:
* Patient requests that patient health data not be included in the analysis
Source: ClinicalTrials.gov (NCT07376889). StuddyBuddy aggregates publicly available trial information.